As a critical molecule in the onset and sustainment of inflammatory response, the receptor
for advanced glycation end products (RAGE) has a variety of ligands, such as advanced …

Obesity and type 2 diabetes mellitus (T2DM) are chronic pathologies with a high incidence
worldwide. They share some pathological mechanisms, including hyperinsulinemia, the …

Isoforms of the receptor for advanced glycation end-product (RAGE) protein, which lack the
transmembrane and the signaling (soluble RAGE or sRAGE) domains are hypothesized to …

The receptor for advanced glycation end-products (RAGE) recognizes several ligands
involved in inflammatory diseases. Two circulating soluble isoforms exist: esRAGE derived …

Nearly 40% of Americans have obesity and are at increased risk for developing type 2
diabetes. Skeletal muscle is responsible for> 80% of insulin-stimulated glucose uptake that …

Cardiometabolic disorders are characterised by a cluster of interactive risk determinants
such as increases in blood glucose, lipids and body weight, as well as elevated …

Aim To evaluate the role of advanced glycation end-products (AGEs) and their soluble
receptors (sRAGE) expression levels as predictors of vascular complications in uncontrolled …

Obesity, a chronic multifaceted disease, predisposes its patients to increased risk of
metabolic disorders such as: diabetes mellitus, cardiovascular diseases, dyslipidemia, etc …

RAGE is a multi-ligand transmembrane glycoprotein that promotes biological signals
associated with inflammatory responses and degenerative diseases. sRAGE is a soluble …

Background Several studies have highlighted the possible positive effects of soluble
receptor for advanced glycation end products (sRAGE) against obesity. However, due to …